# Use of Pharmacogenetics in the Treatment of Children With Autistic Spectrum Disorders

> **NCT00859664** · — · UNKNOWN · sponsor: **Assaf-Harofeh Medical Center** · enrollment: 500 (estimated)

## Conditions studied

- Autism
- Neuroleptic Treatment

## Interventions

- **OTHER:** Genotyping of Cytochrome P450

## Key facts

- **NCT ID:** NCT00859664
- **Lead sponsor:** Assaf-Harofeh Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-03
- **Primary completion:** 2011-07
- **Final completion:** 2011-07
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2009-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00859664

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00859664, "Use of Pharmacogenetics in the Treatment of Children With Autistic Spectrum Disorders". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00859664. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*